Skip to main content

“Our aim is to preserve the patient’s quality of life while treating the tumour as effectively as possible.”

Dr Alexandre Peltier,
Urological surgeon

How we treat the prostate cancers

Prostate cancer is the most common cancer in men. The Institut Jules Bordet has the cutting-edge technology needed to detect and treat these tumours.

The PSA (1) blood test and clinical examination remain the first examinations carried out if prostate cancer is suspected. But they are not the only examinations.

The Institut Jules Bordet is a pioneer in the use of new medical imaging technology for the diagnosis and monitoring of prostate cancer.

  • A multiparametric MRI scan of the prostate offers greater diagnostic precision.
  • Using the Koelis© system, it is possible to merge ultrasound and MRI images to provide real-time 3D images. This enables “mapping” of the prostate and targeted biopsies to be carried out. The Institut Jules Bordet is the first hospital in Belgium to offer this system combined with high-energy focused ultrasound to treat prostate cancers in a highly targeted and personalised way.
  • The Ga68-PSMA (2) PET scan, with its specific isotope, helps detect very small prostatic lesions and to assess the precise extent of the tumour and recurrence following treatment.
  1. Prostate Specific Antigen
  2. Gallium 68 Prostate Specific Membrane Antigen